Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Key Points: Single-cell gene expression analysis reveals CML stem cell heterogeneity and changes imposed by TKI therapy. A subpopulation with primitive, quiescent signature and increased survival to therapy can be high-purity captured as CD45RA−cKIT−CD26+.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TKI treatment has also been shown to induce a stemness signature in CML-LSCs.8,9”
From Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia (2024) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Mahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Cell intrinsic alterations underlie hematopoietic stem cell aging
Rossi, D. J., Bryder, D., Zahn, J. M., Ahlenius, H., Sonu, R., Wagers, A. J., & Weissman, I. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503280102 · Cited by 1,152 · cited 2×
“The HSC population from the nBM control was to a large extent made up by subpopulations expressing primitive or early myeloid molecular, quiescent signatures, likely reflecting the myeloid bias that has been reported in aged HSCs.37,38 However, in the diagnostic BCR-ABLpos LSC population, this heterogeneity was skewed…”
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors
Paul, F., Arkin, Y., Giladi, A., Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Winter, D., Lara-Astiaso, D., Gury, M., Weiner, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.013 · Cited by 1,082
Guo, G., Huss, M., Tong, G. Q., Wang, C., Li Sun, L., Clarke, N. D., & Robson, P. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.012 · Cited by 815
Cited by
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Giustacchini, A., Thongjuea, S., Barkas, N., Woll, P. S., Povinelli, B. J., Booth, C. A. G., Sopp, P., Norfo, R., Rodriguez-Meira, A., Ashley, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4336 · Cited by 403
Self-citationThe leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
Vetrie, D., Helgason, G. V., & Copland, M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0230-9 · Cited by 349
Loh, J.-J., & Ma, S. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.04.004 · Cited by 314
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Yu, S., Yi, M., Qin, S., & Wu, K. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1057-4 · Cited by 264
“hematopoietic stem cell [61] showed cytotoxicity against IL-1RAP-positive cell lines or primary CML cells and induced secretion of pro-inflammatory cytokines in vitro and in vivo.”
Background
Metadata
- Authors
- Warfvinge, R., Geironson, L., Sommarin, M. N. E., Lang, S., Karlsson, C., Roschupkina, T., Stenke, L., Stentoft, J., Olsson-Strömberg, U., Hjorth-Hansen, H., Mustjoki, S., Soneji, S., Richter, J., & Karlsson, G.
- Affiliations
- Division of Molecular Hematology, and
- Lund University (SE)
- Karolinska University Hospital (SE)
- Aarhus University Hospital (DK)
- Department of Medical Science, and
- Department of Hematology, St. Olavs Hospital, Trondheim, Norway;
- University of Helsinki (FI)
- Corresponding author
- Warfvinge, Rebecca
- Geironson, Linda
- Sommarin, Mikael N. E.
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-04-27
- Volume
- 129
- Issue
- 17
- Pages
- 2384-2394
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC5484462
- OpenAlex
- W2580232087
- Cited by
- 154
- References
- 46
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 11 · 2023: 21 · 2022: 15 · 2021: 28 · 2020: 37 · 2019: 13 · 2018: 10 · 2017: 9
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, leukemia stem cells, stem cell heterogeneity, tyrosine kinase inhibitor therapy, treatment resistance, CD45RA, CD117, CD26, immunophenotype, quiescent stem cells, single-cell gene expression
- MeSH terms
- Antineoplastic Agents, Humans, Biomarkers, Tumor, Neoplastic Stem Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gene Expression, Case-Control Studies, Immunophenotyping, Treatment Outcome, Leukocyte Common Antigens, Genetic Heterogeneity, Dipeptidyl Peptidase 4, Antigens, CD34, Proto-Oncogene Proteins c-kit, Cell Lineage, Protein Kinase Inhibitors, ADP-ribosyl Cyclase 1, Interleukin-1 Receptor Accessory Protein, Interleukin-2 Receptor alpha Subunit, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML. https://app.cochat.ai/papers/10.1182/blood-2016-07-728873
- The paper
- Warfvinge, R., Geironson, L., Sommarin, M. N. E., Lang, S., Karlsson, C., Roschupkina, T., Stenke, L., Stentoft, J., Olsson-Strömberg, U., Hjorth-Hansen, H., Mustjoki, S., Soneji, S., Richter, J., & Karlsson, G. (2017). Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML. Blood. https://doi.org/10.1182/blood-2016-07-728873
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.